Oncology
Investigating cancer biology to identify potential targets for future therapies.
Edwin BioTech brings AI-native discovery and wearable health technologies together to advance research and human wellness.
01 / Research
We use advanced AI models to surface and prioritize research hypotheses in oncology and metabolic health.
Investigating cancer biology to identify potential targets for future therapies.
Studying the mechanisms that shape glucose regulation and metabolic health.
Exploring why tissues respond less effectively to insulin and where interventions might help.
02 / Platform
We are developing two complementary capabilities: AI-native research for target discovery and wearable technologies for everyday wellness.
Foundation models and computational analysis to prioritize targets for further study.
Exploring how signals from everyday wearables can support personal wellness and decentralized clinical research.
Digital Health / Product in development
We’re developing a decentralized clinical trial (DCT) product on our Digital Health platform. It’s designed to connect participants, local study teams, and sponsors across countries, so selected study activities can happen outside a central site.
Discuss a DCT partnership
Virtual check-ins and participant-reported outcomes, with local or in-person visits when the study calls for them.
Remote collection of study measures using devices and schedules selected for the protocol.
A shared view of study activities and data completeness for sponsors and participating site teams.
03 / Our Network
Headquartered in San Francisco, with research teams across North America, Europe and Asia.
We welcome collaborations with biopharma and technology teams to advance AI-enabled discovery and shape the future of health management and care.